Timing, Type of Food Intake Linked to Mortality Risks in Diabetes
THURSDAY, March 24, 2022 (HealthDay News) -- Eating less processed meat in the evening may reduce the risk for cardiovascular death among people living with diabetes, according to a study published online March 15 in the Journal of Clinical Endocrinology & Metabolism.
Wenbo Jiang, from Harbin Medical University in China, and colleagues investigated whether food intake time across three meals is associated with long-term survival among people with diabetes. The analysis included 4,642 patients with diabetes participating in the U.S. National Health and Nutrition Examination Survey (2003 to 2014).
The researchers found that higher intake of potato (hazard ratio [HR], 0.46,) or starchy vegetable (HR, 0.32) in forenoon, whole grain (HR, 0.67) in the afternoon, and dark vegetable (HR, 0.55) and milk (HR, 0.56) in the evening was associated with lower cardiovascular disease (CVD) mortality risk. Switching 0.1 serving of potato or starchy vegetable consumed in the afternoon or evening to the forenoon, 0.1 serving of dark vegetable consumed in the afternoon to the evening, and 0.1 serving of whole grain in the forenoon to the afternoon may reduce the risk for CVD mortality.
"Nutritional guidelines and intervention strategies for diabetes should integrate the optimal consumption times for foods in the future," a coauthor said in a statement.
Abstract/Full Text (subscription or payment may be required)
Related Posts
La ivermectina y Luvox fracasan como tratamientos para la COVID-19
JUEVES, 18 de agosto de 2022 (HealthDay News) -- Dos medicamentos que se...
Hay mucho en juego antes del voto de un panel de la FDA sobre un medicamento para la ELA
LUNES, 28 de marzo de 2022 (HealthDay News) -- Unos grupos de defensoría...
More Athletes Are Getting Their Nutrition Through an IV. This Should Stop, Experts Say
WEDNESDAY, Aug. 17, 2022 (HealthDay News) -- Pro athletes appear to be regularly...
Recommendations Developed for Acetaminophen Poisoning
THURSDAY, Aug. 10, 2023 (HealthDay News) -- In a consensus statement published...